Newsletters
Tempus Receives FDA Approval for Tumor Only xT CDx, Enabling Migration of its Entire DNA Solid Tumor Portfolio
[Tempus AI, Inc.] Tempus AI, Inc. announced that the US FDA has granted approval for a tumor-only indication for its xT companion diagnostic next-generation sequencing platform.
Macrophage USP9X Attenuates Colitis by Restricting Oncostatin M Production via K27-Linked Deubiquitination of STAT1
[Cellular & Molecular Immunology] Researchers identified ubiquitin-specific peptidase 9X (USP9X) as a critical negative regulator of intestinal inflammation. USP9X expression is reduced in Ulceralative Colitis patients and inversely correlates with disease severity.
Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate Cancer
[Molecular Cancer Research] Scientists characterized the expression landscape of KLK2 and STEAP1 in metastatic CRPC and defined associated transcriptomic, genomic, and epigenomic features.
PU.1 Is a Mediator of the Reactive Stromal Response Associated with Castration-Resistant Prostate Cancer
[Communications Biology] Researchers characterized the molecular composition of the tumor microenvironment of androgen-sensitive and CRPC by utilizing patient-derived xenograft models.
Ferroptosis Vulnerability of Enzalutamide Resistant Prostate Cancer Conferred by ACSL4 Overexpression and GPX4 Antagonism
[Cell Death & Disease] Scientists utilized their established enzalutamide-resistant prostate cancer cell lines to reveal a vulnerability of these cancer cells to GPX4-targeted ferroptosis.
Interplay of the 3D Genome and Epigenome in Androgen-Driven Prostate Cancer
[Epigenomics] Scientists presented a perspective on how the spatial architecture of the epigenome, including 3D chromatin structure and dynamics, orchestrates dysregulation of transcription factor networks that help to drive disease progression in androgen-driven prostate cancer.
Integrative Advances in Biomarker-Driven Prostate Cancer Management from Genomic Discovery to Precision Oncology
[Discover Oncology] The authors review recent advances in prostate cancer biomarkers, encompassing genetic, proteomic, liquid biopsy, and imaging-based approaches. Genetic mutations inform disease prognosis and therapy selection, while proteomic biomarkers elucidate molecular mechanisms and therapeutic targets.
28bio Launches CNS-3D Inflammatory Organoids to Predict Anti-inflammatory Therapeutic Efficacy
[28bio (BioSpace)] 28bio announced CNS-3D Inflammatory Organoids, designed to evaluate efficacy of anti-inflammatory drugs by quantifying their ability to reduce inflammatory injury, preserve tissue health, and restore neuronal network activity.
Human Amygdala-Like Telencephalic Organoids Model Stress Circuitry in Assembloid Systems
[Cell Stem Cell] Researchers generated human amygdala-like telencephalic organoids (hATOs) that recapitulated cellular composition, region-specific development, and key features of the amygdala. They highlight the potential of hATOs to understand molecular features of affective circuitry underlying emotion.
An Appendiceal Cancer Organoid Biobank Identifies Phenotypic Evolution and Druggable Dependencies of Peritoneal Carcinomatosis
[Developmental Cell] Scientists established a stable biobank of 16 long-term cultured appendiceal adenocarcinoma (AC) patient-derived tumor organoids. Single-cell profiling reveals dedifferentiation from differentiated states in primary AC into intestinal stem cell and fetal progenitor states in AC-peritoneal carcinomatosis, with upregulation of oncogenic signaling pathways.
Integrative Multi-Omics and Network Perturbation Analysis in Human Airway Organoids Reveals Product-Specific Toxicity Profiles of Heated Tobacco Products
[Ecotoxicology and Environmental Safety] The authors established a hPSC-derived airway organoid platform and systematically compared the toxicological profiles of two heated tobacco product aerosols.
Skin Organoid Diversity and Applications in Biomedical Research: A Comprehensive Review
[Cell Biomaterials] The application of skin organoid models in the biomedical field is of great significance for the treatment of rare diseases such as genetic diseases, the tissue repair of large wounds caused by scleroderma or frostbite, and patient-specific drug screening.

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
